Walvax Biotechnology Revenue

Walvax Biotechnology had revenue of 708.00M CNY in the quarter ending September 30, 2024, a decrease of -28.51%. This brings the company's revenue in the last twelve months to 3.10B, down -31.76% year-over-year. In the year 2023, Walvax Biotechnology had annual revenue of 4.11B, down -19.12%.

Revenue (ttm)

3.10B

Revenue Growth

-31.76%

P/S Ratio

5.87

Revenue / Employee

1.30M

Employees

2,388

Market Cap

18.17B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.11B	-972.67M	-19.12%
Jan 1, 2023	5.09B	1.62B	46.89%
Jan 1, 2022	3.46B	523.81M	17.82%
Dec 31, 2020	2.94B	1.82B	162.13%
Dec 31, 2019	1.12B	246.90M	28.24%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	26.00B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	38.50B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Aier Eye Hospital Group	20.62B
Yunnan Baiyao Group Co.,Ltd	39.34B
Shanghai United Imaging Healthcare	10.93B
Beijing Wantai Biological Pharmacy Enterprise	2.49B

Revenue Rankings